Breaking difficult news to patients is something that, as doctors, we have to do. Are there approaches that make it easier and clearer for the patient? In this segment, Dr. Alan Astrow, director of the division of hematology and medical oncology at Maimonides Cancer Center in New York City, joins host Dr. Leslie Lundt to discuss specific case examples of how to break difficult and often complicated news to patients. Dr. Astrow has a special interest in the treatment of breast cancer, gynecological cancers and Hodgkin's and non-Hodgkin's lymphomas. He has conducted research on how to help physicians understand a patient's wishes, values and needs as well as how to improve communication between doctor and patient.
Strategies for Communicating Bad News to Patients
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Overview
Breaking difficult news to patients is something that, as doctors, we have to do. Are there approaches that make it easier and clearer for the patient? In this segment, Dr. Alan Astrow, director of the division of hematology and medical oncology at Maimonides Cancer Center in New York City, joins host Dr. Leslie Lundt to discuss specific case examples of how to break difficult and often complicated news to patients. Dr. Astrow has a special interest in the treatment of breast cancer, gynecological cancers and Hodgkin's and non-Hodgkin's lymphomas. He has conducted research on how to help physicians understand a patient's wishes, values and needs as well as how to improve communication between doctor and patient.
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
Advances in MASLD/MASH: Treating the Liver, the Disease, and the Patient – Chair’s Perspective
IgG4-RD Case Conversations: Diagnosing Pancreaticobiliary Manifestations and Ruling Out Malignancy
Diagnosis and Management of Metastatic PDAC
Chemotherapy Strategies for Metastatic PDAC
TIME OUT: A Case-Based Deep Dive into the Challenges of ARIA Management
A Practical Guide to Prescribing in HF
Clinical Conundrums in ARIA: Nuances of Microhemorrhages when Evaluating an MRI for ARIA
Distinguishing Between Anti-PD-1 Agents in ESCC Combination Therapies
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?